Celularity Inc. is a biotechnology firm that develops placental-derived cell therapies to treat various ailments, including cancer, immune system disorders, and infectious diseases, under the Cell Therapy, Degenerative Disease, and BioBanking segments. The company's clinical programs range from placental-derived CAR-T and natural killer cells to mesenchymal stem-like stromal cells. In addition to cell product development and commercialization, Celularity also offers products for the surgical and wound care markets as well as cord blood banking services under its LifebankUSA brand.